Scotland has approved its first CLDN18.2-targeted therapy for advanced gastric and GEJ cancer, expanding options for patients with HER2-negative disease.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/new-precision-drug-gastric-cancer-approved-scotland-2026a1000257?src=rss
Author :
Publish date : 2026-01-22 12:45:00
Copyright for syndicated content belongs to the linked Source.
